Unmet Needs and Emerging Trends in AML: ASCO 2025 Insights
2 Articles
2 Articles
Advisers still unfairly carrying AML/CTF costs for product providers
Financial advisers and licensees are still at risk of picking up the cost of Customer Due Diligence and Know Your Client (KYC) obligations for product manufacturers under AUSTRAC’s revised anti-money laundering/counter terrorism financing regime. The Financial Advice Association of Australia (FAAA) has expressed disappointment that AUSTAC has failed to pick up on changes which would ensure product manufacturers carried their fair share of costs …
Unmet Needs and Emerging Trends in AML: ASCO 2025 Insights
A panelist discusses how the highest unmet needs in acute myeloid leukemia include treatments for patients with refractory and relapsed disease, addressing poor outcomes in patients with TP53 mutations and MECOM rearrangements, while emerging trends focus on combination therapies (doublets, triplets, quadruplets), the shift toward more convenient oral therapies, increased emphasis on minimal residual disease negativity as an end point, and expan…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium